Enanta Pharmaceuticals (ENTA) Return on Assets [ROA] (2013 - 2026)
Enanta Pharmaceuticals (ENTA) posted Return on Assets [ROA] of -20.68% for fiscal Q3 2026 (quarter ended Jun 30, 2026), up 8.81 percentage points from -29.49% a year earlier but down 1.43 percentage points from the prior quarter.
Powered by 
Analysis
Enanta Pharmaceuticals (ENTA) Return on Assets [ROA] (2013 - 2026) Analysis & Trends
For FY2025 (ended Sep 30, 2025), Enanta Pharmaceuticals' Return on Assets [ROA] came in at -24.91%, up 2.75 percentage points from FY2024.
- Annual Return on Assets [ROA] shows a five-year change of -17.50 percentage points (FY2020 to FY2025).
- In prior fiscal years, Enanta Pharmaceuticals' Return on Assets [ROA] was -27.67% in FY2024 (+4.28 pp), -31.95% in FY2023 (-2.04 pp), -29.91% in FY2022 (-12.83 pp) and -17.08% in FY2021 (-9.67 pp).
- Quarterly Return on Assets [ROA] has run from a low of -37.00% in fiscal Q2 2023 to a high of -19.24% in fiscal Q2 2026 over five years.
- On a year-over-year basis, Return on Assets [ROA] has increased in each of the last four quarters, with an average year-over-year change of +3.39 percentage points over the last eight quarters.
- The strongest year-over-year quarter for Return on Assets [ROA] in the past five years was fiscal Q2 2026, with a gain of 9.47 percentage points; the weakest was fiscal Q1 2022, with a drop of 14.17 percentage points.
- According to Business Quant data, Return on Assets [ROA] for the three prior fiscal quarters was -19.24% (Q2 2026), -23.45% (Q1 2026) and -28.15% (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 19.00% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 8.08% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 7.32% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 1.87% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 9.36% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 9.80% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -7.67% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 2.00% |
| 10 | Enanta Pharmaceuticals | 326.73 Mn | -401.27 Mn | - | -20.68% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -20.68% |
| Mar 31, 2026 | -19.24% |
| Dec 31, 2025 | -23.45% |
| Sep 30, 2025 | -28.15% |
| Jun 30, 2025 | -29.49% |
| Mar 31, 2025 | -28.71% |
| Dec 31, 2024 | -28.93% |
| Sep 30, 2024 | -29.93% |
| Jun 30, 2024 | -28.39% |
| Mar 31, 2024 | -31.29% |
| Dec 31, 2023 | -31.04% |
| Sep 30, 2023 | -27.95% |
| Jun 30, 2023 | -32.15% |
| Mar 31, 2023 | -37.00% |
| Dec 31, 2022 | -33.37% |
| Sep 30, 2022 | -32.01% |
| Jun 30, 2022 | -30.30% |
| Mar 31, 2022 | -26.51% |
| Dec 31, 2021 | -26.16% |
| Sep 30, 2021 | -20.97% |
API Access
Enanta Pharmaceuticals Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=ENTA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "ENTA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=ENTA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();